Inhibition of cyclin-dependent kinases, GSK-3beta and CK1 by hymenialdisine, a marine sponge constituent (Q27621242)

12

object named as

E M Mandelkow

0 references

author name string

L Meijer

1

0 references

A M Thunnissen

2

0 references

A W White

3

0 references

M Nikolic

5

0 references

L H Tsai

6

0 references

J Walter

7

0 references

K E Cleverley

8

0 references

P C Salinas

9

0 references

Y Z Wu

10

0 references

J Biernat

11

0 references

S H Kim

13

0 references

G R Pettit

The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease

14

0 references

publication date

January 2000

0 references

published in

Chemistry and Biology

0 references

volume

7

0 references

page(s)

51-63

0 references

issue

1

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

Tau in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

Phosphorylation of tau protein by casein kinase-1 converts it to an abnormal Alzheimer-like state.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

Proteolysis by presenilins and the renaissance of tau.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

Alzheimer's disease: clues from flies and worms

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

The presenilin 1 protein is a component of a high molecular weight intracellular complex that contains beta-catenin

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

Destabilization of beta-catenin by mutations in presenilin-1 potentiates neuronal apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

Presenilin 1 associates with glycogen synthase kinase-3beta and its substrate tau

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

Activation of tau protein kinase I/glycogen synthase kinase-3beta by amyloid beta peptide (25-35) enhances phosphorylation of tau in hippocampal neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

Cyclin-dependent kinases: engines, clocks, and microprocessors

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

Implication of cyclin-dependent kinases and glycogen synthase kinase 3 in the phosphorylation of microtubule-associated protein 1B in developing neuronal cells

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

The p35/Cdk5 kinase is a neuron-specific Rac effector that inhibits Pak1 activity

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

Association of neurofilament proteins with neuronal Cdk5 activator.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

Chemical inhibitors of cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

CDK inhibition and cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

Inhibition of cyclin-dependent kinases by purine analogues.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human cdk2 complexed with roscovitine

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

Potent inhibition of CDC2 kinase activity by the flavonoid L86-8275.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

Paullones, a series of cyclin-dependent kinase inhibitors: synthesis, evaluation of CDK1/cyclin B inhibition, and in vitro antitumor activity

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

Antineoplastic agents. 362. Isolation and X-ray crystal structure of dibromophakellstatin from the Indian ocean sponge Phakellia mauritiana

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

Progress in the discovery of biosynthetic anticancer drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

Characterization of a yellow compound isolated from the marine sponge Phakellia flabellata

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

Marine natural products. XII. On the chemical constituents of the Okinawan marine sponge Hymeniacidon aldis.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

Antineoplastic agents. 168. Isolation and structure of axinohydantoin

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

Proteolytic fragments of the Alzheimer's disease associated presenilins-1 and -2 are phosphorylated in vivo by distinct cellular mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

Phosphorylation of insulin receptor substrate 1 by glycogen synthase kinase 3 impairs insulin action

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

Multiple modes of ligand recognition: crystal structures of cyclin-dependent protein kinase 2 in complex with ATP and two inhibitors, olomoucine and isopentenyladenine

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

Protein kinase inhibition by staurosporine revealed in details of the molecular interaction with CDK2

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

Stereochemistry of polypeptide chain configurations

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

High-resolution crystal structures of human cyclin-dependent kinase 2 with and without ATP: bound waters and natural ligand as guides for inhibitor design

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

Structural basis of cyclin-dependent kinase activation by phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

WNT-7a induces axonal remodeling and increases synapsin I levels in cerebellar neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

Sequential phosphorylation of Tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

Chemical defense of the Caribbean sponge Agelas clathrodes (Schmidt)

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

Synthesis of C(11)N(5) Marine Sponge Alkaloids: (+/-)-Hymenin, Stevensine, Hymenialdisine, and Debromohymenialdisine

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

Cyclin-dependent kinase 5 and mitogen-activated protein kinase in glial cytoplasmic inclusions in multiple system atrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

Alterations in cyclin-dependent protein kinase 5 (CDK5) protein levels, activity and immunocytochemistry in canine motor neuron disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

A molecular mechanism for the effect of lithium on development

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

Lithium inhibits Alzheimer's disease-like tau protein phosphorylation in neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

Lithium reduces tau phosphorylation: effects in living cells and in neurons at therapeutic concentrations.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

Effects of a protein kinase C inhibitor (PKCI) on the development of adjuvant-induced arthritis (AA) in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

Purification and crystallization of human cyclin-dependent kinase 2.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

Processing of X-ray diffraction data collected in oscillation mode

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

The CCP4 suite: programs for protein crystallography

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

PROCHECK: a program to check the stereochemical quality of protein structures

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

Crystal structure of cyclin-dependent kinase 2

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification 1

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900063-6

7 January 2021

10.1016/S1074-5521(00)00063-6

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1494503

1494503

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference